NCGC00018102-06,
Spectrum_001208,
AC1L1FST,
Prestwick0_000312,
Prestwick1_000312,
Spectrum2_001382,
Spectrum3_001418,
Spectrum4_000827,
CBiol_001758,
Oprea1_381078,
FLUNARIZINE IMPURITY D,
KBioGR_000061,
KBioGR_001373,
KBioSS_000061,
KBioSS_001688,
DivK1c_000043,
SPBio_001364,
SPBio_002523,
CHEMBL3195822,
CTK4I2672,
KBio1_000043,
KBio2_000061,
KBio2_001688,
KBio2_002629,
KBio2_004256,
KBio2_005197,
KBio2_006824,
KBio3_000121,
KBio3_000122,
KBio3_002316,
NINDS_000043,
Bio1_000044,
Bio1_000533,
Bio1_001022,
Bio2_000061,
Bio2_000541,
MCULE-1376135967,
FT-0630654,
1-[bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine,
Piperazine,1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propen-1-yl)-,
693765-11-6,
Sibelium,
MK-2206 2HCl,
CID3378,
1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine,
1-[bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-en-1-yl)piperazine,
52468-60-7,
1032350-13-2,
40218-96-0,
8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one,